Variant report
Variant | rs1880119 |
---|---|
Chromosome Location | chr7:6615440-6615441 |
allele | A/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:32)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:32 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr7:6615150-6615605 | HepG2 | liver: | n/a | n/a |
2 | POLR2A | chr7:6615362-6616459 | HepG2 | liver: | n/a | n/a |
3 | NR2F2 | chr7:6614982-6615677 | HepG2 | liver: | n/a | n/a |
4 | MXI1 | chr7:6615266-6615545 | HepG2 | liver: | n/a | n/a |
5 | MYC | chr7:6615348-6615544 | HepG2 | liver: | n/a | n/a |
6 | HNF4A | chr7:6615204-6615465 | HepG2 | liver: | n/a | n/a |
7 | RXRA | chr7:6615214-6615569 | HepG2 | liver: | n/a | n/a |
8 | EP300 | chr7:6614931-6615653 | HepG2 | liver: | n/a | chr7:6615119-6615128 |
9 | HDAC2 | chr7:6615182-6615567 | HepG2 | liver: | n/a | chr7:6615260-6615274 |
10 | POLR2A | chr7:6614876-6616489 | HepG2 | liver: | n/a | n/a |
11 | HNF4A | chr7:6615186-6615518 | HepG2 | liver: | n/a | n/a |
12 | HEY1 | chr7:6615263-6616491 | HepG2 | liver: | n/a | n/a |
13 | SP1 | chr7:6615103-6615631 | HepG2 | liver: | n/a | n/a |
14 | HNF4G | chr7:6615269-6615531 | HepG2 | liver: | n/a | n/a |
15 | POLR2A | chr7:6614858-6616471 | HepG2 | liver: | n/a | n/a |
16 | FOXA1 | chr7:6615167-6615853 | HepG2 | liver: | n/a | n/a |
17 | MAX | chr7:6615132-6615761 | HepG2 | liver: | n/a | n/a |
18 | FOXA1 | chr7:6615172-6615813 | HepG2 | liver: | n/a | n/a |
19 | TBP | chr7:6614907-6615544 | HepG2 | liver: | n/a | n/a |
20 | EP300 | chr7:6615051-6615490 | HepG2 | liver: | n/a | chr7:6615119-6615128 |
21 | BHLHE40 | chr7:6615127-6615537 | HepG2 | liver: | n/a | n/a |
22 | MAX | chr7:6615351-6615550 | HepG2 | liver: | n/a | n/a |
23 | POLR2A | chr7:6615305-6615565 | HepG2 | liver: | n/a | n/a |
24 | MYBL2 | chr7:6615119-6615817 | HepG2 | liver: | n/a | n/a |
25 | TEAD4 | chr7:6614846-6615862 | HepG2 | liver: | n/a | n/a |
26 | MYBL2 | chr7:6614917-6615677 | HepG2 | liver: | n/a | n/a |
27 | FOXA2 | chr7:6615206-6615527 | HepG2 | liver: | n/a | n/a |
28 | FOXA1 | chr7:6615099-6615640 | HepG2 | liver: | n/a | n/a |
29 | POLR2A | chr7:6614908-6619352 | HepG2 | liver: | n/a | n/a |
30 | FOXA1 | chr7:6614794-6615751 | HepG2 | liver: | n/a | n/a |
31 | FOSL2 | chr7:6615228-6615588 | HepG2 | liver: | n/a | n/a |
32 | ARID3A | chr7:6615037-6615691 | HepG2 | liver: | n/a | n/a |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:6614342..6622557-chr7:6625132..6631922,18 | K562 | blood: | |
2 | chr7:6614289..6616112-chr7:6628784..6631190,2 | K562 | blood: | |
3 | chr7:5921888..5923776-chr7:6615172..6617060,2 | K562 | blood: | |
4 | chr7:6521171..6524635-chr7:6615181..6617344,3 | K562 | blood: | |
5 | chr7:6612729..6615949-chr7:6673669..6677097,3 | K562 | blood: | |
6 | chr7:6536495..6538201-chr7:6614810..6616911,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZDHHC4 | TF binding region |
ENSG00000269781 | Chromatin interaction |
ENSG00000232581 | Chromatin interaction |
ENSG00000136240 | Chromatin interaction |
ENSG00000205903 | Chromatin interaction |
ENSG00000146576 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10235760 | 0.83[CEU][hapmap];0.85[CHB][hapmap];0.90[JPT][hapmap] |
rs10239018 | 0.84[EUR][1000 genomes] |
rs10254630 | 0.92[JPT][hapmap] |
rs10255168 | 0.85[EUR][1000 genomes] |
rs10276346 | 0.89[AMR][1000 genomes];0.91[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs10279458 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10282220 | 0.88[EUR][1000 genomes] |
rs10951987 | 0.91[AMR][1000 genomes];0.97[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs10951988 | 0.86[CEU][hapmap];0.81[AMR][1000 genomes];0.89[EUR][1000 genomes] |
rs11559146 | 0.83[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs11559147 | 0.93[CHB][hapmap];1.00[JPT][hapmap];0.83[ASN][1000 genomes] |
rs11762346 | 0.81[CHB][hapmap];0.85[EUR][1000 genomes] |
rs11762851 | 0.84[EUR][1000 genomes] |
rs11763814 | 0.87[CEU][hapmap];0.85[CHB][hapmap];0.82[JPT][hapmap];0.88[EUR][1000 genomes] |
rs11770467 | 0.88[EUR][1000 genomes] |
rs12532758 | 0.95[EUR][1000 genomes] |
rs12538002 | 0.88[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.82[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs12538197 | 0.92[AMR][1000 genomes];0.99[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12539700 | 0.92[ASN][1000 genomes] |
rs12669808 | 0.90[AMR][1000 genomes];0.97[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs12702529 | 0.89[AMR][1000 genomes];0.93[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs13224458 | 0.84[AMR][1000 genomes];0.85[EUR][1000 genomes] |
rs13226346 | 0.82[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs13229391 | 0.88[EUR][1000 genomes] |
rs13229523 | 0.88[EUR][1000 genomes] |
rs13240710 | 0.84[EUR][1000 genomes] |
rs2346263 | 0.95[CEU][hapmap];0.83[JPT][hapmap];0.84[EUR][1000 genomes] |
rs3088114 | 0.81[JPT][hapmap] |
rs34060186 | 0.84[EUR][1000 genomes] |
rs4075107 | 0.96[CEU][hapmap];0.92[JPT][hapmap];0.83[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs4272276 | 0.84[CEU][hapmap];0.92[JPT][hapmap] |
rs56717970 | 0.90[EUR][1000 genomes] |
rs59895610 | 0.86[AMR][1000 genomes];0.96[EUR][1000 genomes] |
rs6943805 | 0.84[EUR][1000 genomes] |
rs6950897 | 0.84[AMR][1000 genomes];0.83[EUR][1000 genomes] |
rs6952785 | 0.90[AMR][1000 genomes];0.99[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs6963775 | 0.80[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs73345000 | 0.93[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7357134 | 0.87[AMR][1000 genomes];0.90[EUR][1000 genomes] |
rs7790874 | 0.92[CEU][hapmap];0.91[JPT][hapmap];0.88[EUR][1000 genomes] |
rs7790928 | 0.91[CEU][hapmap];0.85[JPT][hapmap];0.84[EUR][1000 genomes] |
rs7792808 | 0.92[CEU][hapmap];0.92[JPT][hapmap];0.88[EUR][1000 genomes] |
rs7793367 | 0.80[CEU][hapmap];0.92[JPT][hapmap] |
rs7793685 | 0.88[AMR][1000 genomes];0.96[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs7800917 | 0.85[CHB][hapmap];0.90[JPT][hapmap] |
rs7801415 | 0.88[EUR][1000 genomes] |
rs952042 | 0.83[AMR][1000 genomes];0.84[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv948912 | chr7:5803903-6623553 | Active TSS Flanking Active TSS Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 123 gene(s) | inside rSNPs | diseases |
2 | nsv1034060 | chr7:5814823-6745710 | Bivalent Enhancer Active TSS Weak transcription Flanking Active TSS Enhancers Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 138 gene(s) | inside rSNPs | diseases |
3 | nsv538711 | chr7:5814823-6745710 | Weak transcription ZNF genes & repeats Flanking Active TSS Enhancers Active TSS Genic enhancers Strong transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 138 gene(s) | inside rSNPs | diseases |
4 | nsv1028242 | chr7:5819084-6645024 | Flanking Active TSS Weak transcription Enhancers Bivalent/Poised TSS Strong transcription Bivalent Enhancer Active TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 127 gene(s) | inside rSNPs | diseases |
5 | nsv538712 | chr7:5819084-6645024 | Weak transcription Active TSS Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 127 gene(s) | inside rSNPs | diseases |
6 | nsv949531 | chr7:5949371-6753694 | Strong transcription Bivalent Enhancer Bivalent/Poised TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Active TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 129 gene(s) | inside rSNPs | diseases |
7 | nsv1020236 | chr7:6248930-6690377 | Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
8 | nsv830895 | chr7:6514781-6722092 | Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription Active TSS ZNF genes & repeats Flanking Active TSS Enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
9 | nsv887429 | chr7:6520676-6659509 | Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers Enhancers Weak transcription Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 28 gene(s) | inside rSNPs | diseases |
10 | nsv887430 | chr7:6520676-6668027 | Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS Enhancers Strong transcription Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 28 gene(s) | inside rSNPs | diseases |
11 | nsv508444 | chr7:6534110-6700527 | Bivalent/Poised TSS Strong transcription Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 33 gene(s) | inside rSNPs | diseases |
12 | nsv1025220 | chr7:6534278-6736802 | Flanking Active TSS Active TSS ZNF genes & repeats Weak transcription Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
13 | nsv538717 | chr7:6534278-6736802 | Enhancers Weak transcription Strong transcription ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
14 | nsv887431 | chr7:6535517-6690240 | Active TSS Weak transcription Flanking Active TSS Strong transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 31 gene(s) | inside rSNPs | diseases |
15 | nsv515978 | chr7:6535517-6698905 | Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Strong transcription Bivalent Enhancer Enhancers Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
16 | nsv887432 | chr7:6535517-6713985 | Enhancers Weak transcription ZNF genes & repeats Bivalent/Poised TSS Strong transcription Genic enhancers Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 34 gene(s) | inside rSNPs | diseases |
17 | nsv887433 | chr7:6557135-6668027 | Enhancers ZNF genes & repeats Weak transcription Transcr. at gene 5' and 3' Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Active TSS Flanking Active TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
18 | nsv887434 | chr7:6557135-6713985 | Strong transcription Active TSS Genic enhancers Flanking Active TSS Weak transcription Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
19 | nsv606001 | chr7:6563109-6683454 | Flanking Active TSS Weak transcription Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNA | 29 gene(s) | inside rSNPs | diseases |
20 | nsv606002 | chr7:6567114-6713985 | Weak transcription Flanking Active TSS Active TSS Genic enhancers Strong transcription Bivalent Enhancer Enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
21 | nsv887435 | chr7:6613604-6713985 | Weak transcription Strong transcription Enhancers Genic enhancers Bivalent Enhancer Active TSS Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:6578600-6616200 | Weak transcription | Right Atrium | heart |
2 | chr7:6610400-6615800 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr7:6611400-6615800 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
4 | chr7:6611400-6616600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr7:6611600-6615600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
6 | chr7:6611600-6615800 | Weak transcription | Hela-S3 | cervix |
7 | chr7:6611600-6616000 | Weak transcription | GM12878-XiMat | blood |
8 | chr7:6612200-6616200 | Weak transcription | Fetal Muscle Trunk | muscle |
9 | chr7:6614400-6616400 | Weak transcription | HSMMtube | muscle |
10 | chr7:6614800-6615800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
11 | chr7:6615200-6615800 | Weak transcription | A549 | lung |
12 | chr7:6615200-6616200 | Weak transcription | Ovary | ovary |
13 | chr7:6615400-6616400 | Flanking Active TSS | HepG2 | liver |